Natera
Natera is seeking an experienced Regional Director to build, lead, and develop a team of Clinical Oncology Specialists focused on Genitourinary (GU) cancers across the Eastern United States. This specialized sales team will drive adoption of Natera’s Signatera™ molecular residual disease (MRD) test, with a primary focus on Urologic Oncology. The role involves driving sales performance, ensuring sales goals are achieved, and collaborating with cross-functional teams to develop and execute business strategies.
Headquarters
Austin, Texas, United States
Company Size
1001-5000 employees
Founded
2004
Natera is a molecular diagnostics company that develops and commercializes cell-free DNA testing for oncology, women's health, organ health, and rare disease. Its tests are used for cancer detection and monitoring, noninvasive prenatal and carrier screening, transplant rejection assessment, and genomic analysis for rare diseases. Natera's clinically validated tests are processed in CAP/CLIA-certified labs and supported by over 400 peer-reviewed publications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Natera.
Natera's 1.18% Stock Decline Despite $280M Volume Surge Ranks 429th in Trading Activity
14 hours ago
Medical Director, Clinical Development - MRD Portfolio (Solid Tumors)
Labcorp
Genitourinary (GU) Medical Oncologist
Oracle
Genitourinary (GU) Medical Oncologist
Oracle
MRD Clinical Account Executive, North LA
Tempus AI
Genitourinary (GU) Medical Oncologist
Oracle
Genitourinary (GU) Medical Oncologist
oraclecloudinfrastructure